在使用生物制药和药物动力学的抗超脂血症疗效中,皮佩林和埃泽蒂米布之间的特征和相互作用
Kavitha Marati1, Sujatha Palatheeya1, Ananda Kumar Chettupalli2
1Department of Pharmacology, University College of pharmaceutical Sciences, Palamuru University, Mahbubnagar Rural, Mahbubnagar, Telangana, 509001, India.
BMC pharmacology & toxicology
|January 14, 2025
概括
皮佩林增强了Ezetimibe (EZ) 的抗高脂效应,提高了其生物可用性和功效. 这种组合显示出治疗超脂血症和动脉样硬化的前景.
科学领域:
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 超脂血是诸如动脉样硬化等心血管疾病的关键危险因素.
- 乙胺基 (EZ) 是一种BCS II药物,具有较低的溶解性,因此需要采取提高其生物利用性的策略.
- 作为一种天然的生物增强剂,皮皮林可以增加药物的生物可用性,而不会改变药物的特性或疗效.
研究的目的:
- 为了提高Ezetimibe (EZ) 的溶解性和生物可用性,使用piperine作为生物增强剂.
- 为了评估EZ和piperine的联合抗高脂效和强度.
- 评估皮佩林降低EZ毒性的潜力.
主要方法:
- 在活体中评估使用propylthiouracil和Triton X-100诱导的高脂血症模型对大鼠的抗高脂血症作用.
- 使用EZ (10毫克/体重) 和皮佩林 (5-20 毫克/公斤体重) 在组合. 在组合.
- 血清脂质概况 (TC,TG,LDL,VLDL,HDL) 和肝脏组织学的分析.
主要成果:
- 结合EZ和piperine显著降低了LDL,TC,TG和VLDL的水平 (p<0.01和p<0.05).
- 肝脏组织学证实了治疗大鼠肝脏组织的正常化.
- EZ在4小时内达到最大度 (Cmax),并在24小时内保持可检测性.
结论:
- 与 piperine 结合的 EZ 显示出显著的抗高脂和抗氧化作用.
- 皮佩林增强了EZ的生物可用性和口服吸收,这表明它有可能治疗高脂血症和动脉样硬化.
相关概念视频
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
526
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
526
01:20Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
173
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
173
01:22Dose-Response Relationship: Potency and Efficacy
4.2K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.2K
01:20Antiepileptic Drugs: Potassium Channel Activators
142
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
142
01:24Factors Influencing Drug Absorption: Presystemic Elimination
176
The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
176
01:22Factors Influencing Drug Absorption: Physicochemical Parameters
210
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
210